Combination of Intravitreal Bevacizumab and Topical Dorzolamide versus Intravitreal Bevacizumab Alone for Diabetic Macular Edema: A Randomized Contralateral Clinical Trial

Table 3

CMT after intervention for both groups.

Time	Control		Intervention		P1
	Mean	SD	Mean	SD
Baseline	530	80	505	87	0.341
Month 1	501	91	492	85	0.696
Month 2	487	108	473	86	0.491
P2	0.003		0.013

SD: standard deviation, P₁: between-group value (Mann–Whitney test), P₂: within-group value (Friedman test).